/
•
•
Detailed stories on technology startups, business and economic current affairs.
While earlier attempts were unsuccessful, with Glenmark running into huge losses, there seems to be growing consensus that the drugmaker’s R&D strategy makes it a different company. Perhaps even a valuable one.

As India’s largest stock exchange heads to the public markets, it may need to rethink its excessive reliance on transaction revenue.
April data suggests the slide may be moderating, even as the UAE accelerates moves to derisk its future.
The framework reads less like an agreement between partners and more like a probation order written by the stronger side.